# Smartphone-delivered multicomponent lifestyle medicine intervention for improving mental health in a nonclinical population: a randomized controlled trial

**Authors:** Vincent Wing-Hei Wong, Jessica Tsz-Yan Tong, Nga-Kwan Shi, Chee H. Ng, Jerome Sarris, Fiona Yan-Yee Ho

PMC · DOI: 10.3389/fpubh.2023.1231981 · Frontiers in Public Health · 2024-01-16

## TL;DR

A smartphone-based lifestyle intervention improved mental health in nonclinical adults, showing benefits in reducing symptoms of depression and anxiety.

## Contribution

The study introduces Lifestyle Hub, a multicomponent smartphone-delivered lifestyle medicine intervention for nonclinical mental health improvement.

## Key findings

- Lifestyle Hub significantly improved mental health, depressive symptoms, and anxiety symptoms in nonclinical adults.
- Improvements were maintained at a 1-month follow-up, indicating sustained benefits.
- Participants found the intervention acceptable, though higher attrition was observed in the intervention group.

## Abstract

To prevent the exacerbation of mental health burdens, a growing body of research has recommended a balanced approach that emphasizes both the delivery of mental health treatments to individuals with common mental disorders (CMDs) and the strengthening of protective factors for CMDs among nonclinical populations. This randomized controlled trial (RCT) evaluated the efficacy of a smartphone-delivered multicomponent lifestyle medicine (LM) intervention, Lifestyle Hub, for improving mental health among a nonclinical population of Chinese adults.

A total of 106 participants with Patient Health Questionnaire-9 total score < 10 and Generalized Anxiety Disorder 7-Item Scale <8 were randomly assigned to either the Lifestyle Hub intervention group (LH, n = 53) or the waitlist control group (WL, n = 53). Lifestyle Hub is an 8-week smartphone-delivered multicomponent LM intervention developed based on the transtheoretical model. The intervention components included lifestyle psychoeducation, physical activity, diet and nutrition, stress management, sleep management, and motivation and goal-setting techniques. Assessments were conducted at baseline, immediate post-intervention, and 1-month follow-up (LH only).

The linear mixed effect model based on the intention-to-treat principle indicated that Lifestyle Hub significantly improved overall mental health, depressive symptoms, anxiety symptoms, stress, insomnia severity, overall health-promoting behaviors, dietary quality, and stress management compared to the WL group at immediate post-intervention (d = 0.13–0.56). No significant between-group differences were observed in terms of functional impairment, health-related quality of life, health responsibility, physical activity level, spiritual growth, and interpersonal relations. The intervention gains in the LH group were maintained at 1-month follow-up. The LH participants indicated that Lifestyle Hub was an acceptable intervention for improving mental health, although a significantly higher level of study attrition was observed in the LH group (20.8%) relative to the WL group (5.7%).

Lifestyle Hub may serve as an efficacious and acceptable intervention for improving mental health in nonclinical adult populations. To extend the benefits of LM interventions at the population level, future studies are warranted to examine a stepped-care approach to delivering LM interventions.

Trial registration: This randomized controlled trial was pre-registered with ClinicalTrials.gov (NCT04295369).

## Linked entities

- **Diseases:** depression (MONDO:0002050), anxiety (MONDO:0005618)

## Full-text entities

- **Diseases:** Stress (MESH:D000079225), CMD (MESH:C565145), bodily pain (MESH:D010146), disability (MESH:D009069), anxiety disorders (MESH:D001008), Functional disability (MESH:D003291), Generalized Anxiety Disorder (MESH:C000726808), mental health (OMIM:603663), functional impairment (MESH:D003072), depressed (MESH:D003866), Insomnia (MESH:D007319), Sheehan (MESH:D007018), medical or neurocognitive disorders (MESH:D019965), Depression Anxiety (MESH:D001007), COVID-19 (MESH:D000086382), CMDs (MESH:D001523)
- **Chemicals:** LH (MESH:D007986), CONSORT (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10824847/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10824847/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC10824847/full.md

---
Source: https://tomesphere.com/paper/PMC10824847